![HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast artwork](https://is1-ssl.mzstatic.com/image/thumb/Podcasts113/v4/89/d0/1c/89d01c4e-f16a-b250-50ec-8e5cfee21d11/mza_3581079248703134654.png/100x100bb.jpg)
067 - Diabetes: does it cost a “heart” and a leg?
HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast
English - September 26, 2017 10:00 - 28 minutes - 28.4 MB - ★★★★★ - 549 ratingsMedicine Health & Fitness Education drugs medicine rosalindfranklin medications pharmacist pharmacy pharmd rfums Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: 066 - What’s new in the diabetes world? Tapas style!
In this episode, we discuss new evidence for cardiovascular outcomes in diabetics based on the LEADER trial (liraglutide) and CANVAS trials (canagliflozin). We also discuss the new FDA warning for canagliflozin regarding amputation risk.